Loading insider details...
Beta
Latest Form 4 (Oct 1, 2026): Exercise/Conversion of 921 CNSY shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 1, 2026 | CERENOME, INC. (CNSY) | Exercise/Conversion | 921 | n/a |
| Jul 1, 2026 | PLUS THERAPEUTICS, INC. (PSTV) | Exercise/Conversion | 922 | n/a |
| May 18, 2026 | PLUS THERAPEUTICS, INC. (PSTV) | Grant/Award | 3,686 | n/a |
| Dec 11, 2025 | Savara Inc (SVRA) | Grant/Award | 40,000 | n/a |
| Nov 17, 2025 | Savara Inc (SVRA) | Exercise/Conversion | 5,860 | $8.6K |
| Aug 15, 2025 | PLUS THERAPEUTICS, INC. (PSTV) | Grant/Award | 397,794 | n/a |
| Jun 23, 2025 | Savara Inc (SVRA) | Purchase | 48,225 | $98.6K |
| Feb 20, 2025 | PLUS THERAPEUTICS, INC. (PSTV) | Grant/Award | 40,122 | n/a |
| Dec 16, 2024 | Savara Inc (SVRA) | Grant/Award | 40,000 | n/a |
| Sep 17, 2024 | PLUS THERAPEUTICS, INC. (PSTV) | Purchase | 4,000 | $6.0K |